Overview
Fusidic acid is a steroid antibiotic derived from the fungus Fusidium coccineum. It was first isolated in the 1960s and has since become a critical therapeutic option for infections caused by Staphylococcus aureus, including methicillin-resistant strains (MRSA). Its unique mechanism of action involves inhibiting bacterial protein synthesis by binding to elongation factor G (EF-G), making it valuable in treating resistant infections. Unlike many antibiotics, fusidic acid demonstrates selective activity against Gram-positive bacteria, with minimal effect on Gram-negative organisms. It is commonly formulated as creams, ointments, or systemic preparations for diverse medical applications. The compound's steroidal structure contributes to its anti-inflammatory properties, which complement its antimicrobial effects in topical formulations.
Physical and Chemical Properties
Fusidic acid appears as a white to off-white crystalline powder with a molecular weight of 516.71 g/mol. It decomposes at 192-195°C without a distinct boiling point. The compound is sparingly soluble in water but dissolves readily in organic solvents like ethanol and methanol, a property leveraged in pharmaceutical formulations. Chemically, fusidic acid belongs to the fusidane class of antibiotics, characterized by a tetracyclic triterpenoid structure. This complex architecture contributes to its stability under normal storage conditions but requires protection from light and moisture to prevent degradation. The sodium salt form (fusidate sodium) offers improved water solubility for injectable preparations, though the free acid remains preferred for topical applications due to better skin penetration.
Main Applications
In clinical practice, fusidic acid is primarily employed against Staphylococcal infections, including impetigo, infected wounds, and secondary skin infections. Its ability to penetrate bone and joint tissues makes it particularly effective for osteomyelitis and septic arthritis when administered systemically. Ophthalmologic formulations treat bacterial conjunctivitis and blepharitis. The pharmaceutical industry also utilizes fusidic acid as a combination therapy component, frequently paired with other antibiotics like betamethasone to enhance anti-inflammatory effects. Veterinary medicine applications mirror human uses, addressing mastitis in cattle and skin infections in companion animals. Recent research explores its potential in biofilm disruption and as an adjunct in chronic wound management, expanding its therapeutic scope.
Safety and Storage
Fusidic acid generally exhibits good tolerance but may cause mild gastrointestinal distress or skin irritation in sensitive individuals. Rare cases of hepatotoxicity warrant liver function monitoring during prolonged systemic use. Topical formulations carry lower systemic absorption and consequently fewer side effects. Proper storage requires maintaining the product in its original container at 2-8°C, protected from light and moisture. Bulk pharmaceutical quantities demand controlled environment conditions to preserve stability. The powder form remains stable for approximately 3 years when stored correctly, while formulated products typically have shorter shelf lives as specified by manufacturers. Special disposal protocols apply to expired or contaminated material to prevent environmental antibiotic resistance development.
B2B Procurement Guide
When sourcing fusidic acid for pharmaceutical production, prioritize suppliers with GMP certification and complete analytical documentation. Request certificates of analysis verifying purity (typically ≥98%), heavy metal content, and microbiological quality. Bulk purchases exceeding 1kg often qualify for tiered pricing but may require special import/export permits due to antibiotic regulations. Technical specifications should include particle size distribution for formulation compatibility and residual solvent levels where applicable. Consider conducting independent HPLC testing for critical batches. Lead times for custom synthesis can extend to 8-12 weeks, necessitating advance planning. Emerging markets in Asia now offer competitive pricing, but stringent quality verification remains essential when evaluating new supply chains.
Related Manufacturers
- 主营：科研试剂、高效试剂
- 主营：抗体、感受态、培养基、试剂盒、层析柱、填料、生物试剂、化学试剂
- 主营：研突破、转座酶、重组酶、连接酶、研试剂、(5×)(with、recombinant、结合蛋白、胶体染料、核酸染料、助力科研、大肠杆菌、泛素蛋白、实验室用品、重组肠激酶、电泳缓冲液、拓扑异构酶、热敏磷酸酶、检测试剂盒、全能核酸酶、核酸外切酶、核酸内切酶、连接试剂盒、碱性磷酸酶、微球菌核酸酶
- 主营：微生物菌种、标准菌株、益生菌、食用菌